BioCentury | Jun 22, 2018
Finance

Regenerating eastward

...two new Japanese investors -- the bank Shinsei Group, and the cell therapy manufacturing company Shibuya Corp....
...South Korea Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan Promethera Biosciences S.A., Mont-Saint-Guibert, Belgium Shibuya Corp....
BioCentury | Apr 13, 2018
Company News

Promethera acquires antibody play Baliopharm

...million ($11.4 million) on April 10 through the sale of convertible bonds to new investors Shibuya Corp....
BioCentury | Apr 10, 2018
Company News

Promethera acquires antibody play Baliopharm

...also raised €9.3 million ($11.4 million) through the sale of convertible bonds to new investors Shibuya Corp....
Items per page:
1 - 3 of 3
BioCentury | Jun 22, 2018
Finance

Regenerating eastward

...two new Japanese investors -- the bank Shinsei Group, and the cell therapy manufacturing company Shibuya Corp....
...South Korea Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan Promethera Biosciences S.A., Mont-Saint-Guibert, Belgium Shibuya Corp....
BioCentury | Apr 13, 2018
Company News

Promethera acquires antibody play Baliopharm

...million ($11.4 million) on April 10 through the sale of convertible bonds to new investors Shibuya Corp....
BioCentury | Apr 10, 2018
Company News

Promethera acquires antibody play Baliopharm

...also raised €9.3 million ($11.4 million) through the sale of convertible bonds to new investors Shibuya Corp....
Items per page:
1 - 3 of 3